Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window

[1]  Jingliang Zhang,et al.  Inhibition of intracellular proton-sensitive Ca2+-permeable TRPV3 channels protects against ischemic brain injury , 2022, Acta pharmaceutica Sinica. B.

[2]  M. De Vivo,et al.  Pharmacological tools to target NKCC1 in brain disorders. , 2021, Trends in pharmacological sciences.

[3]  J. Ji,et al.  Sphingosine-1-phosphate, a novel TREM2 ligand, promotes microglial phagocytosis to protect against ischemic brain injury , 2021, Acta pharmaceutica Sinica. B.

[4]  Wendong Xu,et al.  Smoothened is a therapeutic target for reducing glutamate toxicity in ischemic stroke , 2021, Science Translational Medicine.

[5]  Fei Li,et al.  A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABAARs , 2021, Theranostics.

[6]  Xin-Fu Zhou.  ESCAPE-NA1 Trial Brings Hope of Neuroprotective Drugs for Acute Ischemic Stroke: Highlights of the Phase 3 Clinical Trial on Nerinetide , 2021, Neuroscience Bulletin.

[7]  Lei Chang,et al.  Environmental enrichment implies GAT-1 as a potential therapeutic target for stroke recovery , 2021, Theranostics.

[8]  So Yeong Lee,et al.  High Salt Intake Recruits Tonic Activation of NR2D Subunit-Containing Extrasynaptic NMDARs in Vasopressin Neurons , 2020, The Journal of Neuroscience.

[9]  Li-fang Liu,et al.  Orthogonal label and label-free dual pretreatment for targeted profiling of neurotransmitters in enteric nervous system. , 2020, Analytica chimica acta.

[10]  Hyung-Seok Kim,et al.  Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subcortical Stroke. , 2020, Cell reports.

[11]  Lei Chang,et al.  nNOS-expressing neurons in the vmPFC transform pPVT-derived chronic pain signals into anxiety behaviors , 2020, Nature Communications.

[12]  Thalia Shoshana Field,et al.  Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. , 2020, The Lancet.

[13]  Dong Woon Kim,et al.  Bestrophin1‐mediated tonic GABA release from reactive astrocytes prevents the development of seizure‐prone network in kainate‐injected hippocampi , 2019, Glia.

[14]  Zhiping Hu,et al.  Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation , 2019, Front. Neurosci..

[15]  Junhua Yang,et al.  Glutamate-Releasing SWELL1 Channel in Astrocytes Modulates Synaptic Transmission and Promotes Brain Damage in Stroke , 2019, Neuron.

[16]  H. Park,et al.  Control of motor coordination by astrocytic tonic GABA release through modulation of excitation/inhibition balance in cerebellum , 2018, Proceedings of the National Academy of Sciences.

[17]  W. Powers,et al.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2018, Stroke.

[18]  Lei Chang,et al.  Dissociation of nNOS from PSD‐95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes , 2018, The Journal of pathology.

[19]  Lei Chang,et al.  Opening a New Time Window for Treatment of Stroke by Targeting HDAC2 , 2017, The Journal of Neuroscience.

[20]  S. Oh,et al.  Distribution and Function of the Bestrophin-1 (Best1) Channel in the Brain , 2017, Experimental neurobiology.

[21]  John H. Zhang,et al.  Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research , 2017, BioMed research international.

[22]  M. Darlison,et al.  Chloride co‐transporters as possible therapeutic targets for stroke , 2017, Journal of neurochemistry.

[23]  K. Kunzelmann.  TMEM16, LRRC8A, bestrophin: chloride channels controlled by Ca(2+) and cell volume. , 2015, Trends in biochemical sciences.

[24]  Dongyang Huang,et al.  Characterization of the effects of Cl− channel modulators on TMEM16A and bestrophin-1 Ca2+ activated Cl− channels , 2015, Pflügers Archiv - European Journal of Physiology.

[25]  S. Long,et al.  Structure and insights into the function of a Ca2+-activated Cl− channel , 2014, Nature.

[26]  Fengyun Zhang,et al.  Interaction of nNOS with PSD-95 Negatively Controls Regenerative Repair after Stroke , 2014, The Journal of Neuroscience.

[27]  J. A. Payne,et al.  Cation-chloride cotransporters in neuronal development, plasticity and disease , 2014, Nature Reviews Neuroscience.

[28]  K. Kikuchi,et al.  Clinical Trials in Acute Ischemic Stroke , 2014, CNS Drugs.

[29]  Federico N. Soria,et al.  Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. , 2014, The Journal of clinical investigation.

[30]  Yong Jeong,et al.  GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease , 2014, Nature Medicine.

[31]  Y. T. Wang,et al.  Excitotoxicity and stroke: Identifying novel targets for neuroprotection , 2014, Progress in Neurobiology.

[32]  P. Ortinski,et al.  Extrasynaptic Targeting of NMDA Receptors Following D1 Dopamine Receptor Activation and Cocaine Self-Administration , 2013, The Journal of Neuroscience.

[33]  Y. Bae,et al.  TREK-1 and Best1 Channels Mediate Fast and Slow Glutamate Release in Astrocytes upon GPCR Activation , 2012, Cell.

[34]  Mark Ellisman,et al.  DIDS Prevents Ischemic Membrane Degradation in Cultured Hippocampal Neurons by Inhibiting Matrix Metalloproteinase Release , 2012, PloS one.

[35]  Fan Wang,et al.  The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons , 2012, Nature Neuroscience.

[36]  Y. Jan,et al.  Calcium-Activated Chloride Channels (CaCCs) Regulate Action Potential and Synaptic Response in Hippocampal Neurons , 2012, Neuron.

[37]  F. Scamps,et al.  Calcium-activated chloride current expression in axotomized sensory neurons: what for? , 2012, Front. Mol. Neurosci..

[38]  W. Lu,et al.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95 , 2010, Nature Medicine.

[39]  Hee-Sup Shin,et al.  Channel-Mediated Tonic GABA Release from Glia , 2010, Science.

[40]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[41]  C. Roncero,et al.  Transient focal cerebral ischemia significantly alters not only EAATs but also VGLUTs expression in rats: relevance of changes in reactive astroglia , 2010, Journal of neurochemistry.

[42]  S. Traynelis,et al.  Bestrophin-1 Encodes for the Ca2+-Activated Anion Channel in Hippocampal Astrocytes , 2009, The Journal of Neuroscience.

[43]  A. Marmorstein,et al.  Best1 Is a Gene Regulated by Nerve Injury and Required for Ca2+-Activated Cl− Current Expression in Axotomized Sensory Neurons , 2009, The Journal of Neuroscience.

[44]  Claudio Rivera,et al.  Cation-Chloride Cotransporters and Neuronal Function , 2009, Neuron.

[45]  G. Haddad,et al.  DIDS protects against neuronal injury by blocking Toll‐like receptor 2 activated‐mechanisms , 2009, Journal of neurochemistry.

[46]  A. Villringer,et al.  The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke , 2008, Journal of hypertension.

[47]  M. Gobbi,et al.  Neuroprotective Effects of the Novel Glutamate Transporter Inhibitor (–)-3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic Acid, Which Preferentially Inhibits Reverse Transport (Glutamate Release) Compared with Glutamate Reuptake , 2008, Journal of Pharmacology and Experimental Therapeutics.

[48]  E. Lo,et al.  A new penumbra: transitioning from injury into repair after stroke , 2008, Nature Medicine.

[49]  H. C. Hartzell,et al.  Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. , 2008, Physiological reviews.

[50]  G. Haddad,et al.  Cell death in an ischemic infarct rim model , 2007, Journal of neurochemistry.

[51]  S. Shioda,et al.  Anion channel blockers attenuate delayed neuronal cell death induced by transient forebrain ischemia , 2007, Journal of neuroscience research.

[52]  H. C. Hartzell,et al.  The Anion-Selective Pore of the Bestrophins, a Family of Chloride Channels Associated with Retinal Degeneration , 2006, The Journal of Neuroscience.

[53]  Roger J. Thompson,et al.  Ischemia Opens Neuronal Gap Junction Hemichannels , 2006, Science.

[54]  Tian-Le Xu,et al.  Coupling between NMDA Receptor and Acid-Sensing Ion Channel Contributes to Ischemic Neuronal Death , 2005, Neuron.

[55]  D. Attwell,et al.  Tonic release of glutamate by a DIDS‐sensitive mechanism in rat hippocampal slices , 2005, The Journal of physiology.

[56]  P. Fisher,et al.  β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression , 2005, Nature.

[57]  I. Ford,et al.  Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial , 2004, The Lancet.

[58]  P. Stys,et al.  Aberrant Chloride Transport Contributes to Anoxic/Ischemic White Matter Injury , 2003, The Journal of Neuroscience.

[59]  J. Rothstein,et al.  Antisense Knockdown of the Glial Glutamate Transporter GLT-1, But Not the Neuronal Glutamate Transporter EAAC1, Exacerbates Transient Focal Cerebral Ischemia-Induced Neuronal Damage in Rat Brain , 2001, The Journal of Neuroscience.

[60]  K. Lees,et al.  Phase II Clinical Trial of Sipatrigine (619C89) by Continuous Infusion in Acute Stroke , 2000, Cerebrovascular Diseases.

[61]  J. Phillis,et al.  Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with dl-threo-β-benzyloxyaspartate , 2000, Brain Research.

[62]  D. Attwell,et al.  Glutamate release in severe brain ischaemia is mainly by reversed uptake , 2000, Nature.

[63]  M. Metzker,et al.  Identification of the gene responsible for Best macular dystrophy , 1998, Nature Genetics.

[64]  M. Hediger,et al.  Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate , 1996, Neuron.

[65]  D. Attwell,et al.  Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms , 1994, Trends in Neurosciences.

[66]  K. Valentino,et al.  A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Rothstein,et al.  Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[68]  H. Benveniste,et al.  Cellular Origin of Ischemia‐Induced Glutamate Release from Brain Tissue In Vivo and In Vitro , 1985, Journal of neurochemistry.

[69]  G. Feng,et al.  The Chloride Transporter Na+-K+-Cl− Cotransporter Isoform-1 Contributes to Intracellular Chloride Increases after In Vitro Ischemia , 2006, The Journal of Neuroscience.